Carla Warneke, M.S.

Senior Statistical Analyst


  • B.S. in Psychology, Texas A&M University, College Station TX
  • M. S. in Epidemiology, School of Public Health, The University of Texas Health Science Center, Houston TX

Previous Experience

  • Five years working as a Cancer Prevention Specialist, Statistical Analyst, for the Department of Behavioral Science at MD Anderson Cancer Center

Areas of Interest

  • Data analysis
  • SAS programming
  • Epidemiology


Morris LF, Waguespack SG, Edeiken-Monroe BS, Lee JE, Rich TA, Ying AK, Warneke CL, Evans DB, Perrier ND, Grubbs EG. Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening. Annals of Surgical Oncology 2013; 20(1): 53-59.

Landry CS, Grubbs EG, Warneke CL, Ormond M, Chua C, Lee JE, Perrier ND. Robot-assisted transaxillary thyroid surgery in the United States: is it comparable to open thyroid lobectomy? Annals of Surgical Oncology 2012; 19(4): 1269-1274.

Del Fabbro E, Parsons H, Warneke CL, Pulivarthi K, Litton JK, Dev R, Palla SL, Brewster A, Bruera E.The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist 2012; 17(10): 1240-1245.

Esmaeli B, Nasser QJ, Cruz H, Felman M, Warneke CL, Ivan D. American Joint Committee on Cancer T Category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. Ophthalmology 2012; 119(5): 1078-1082.

Colombo C, Creighton CJ, Ghadimi M, Bolshakov S, Warneke CL, Zhang Y, Lusby K, Zhu S, Lazar AJ, West RB, van de Rijn M, Lev D. Increased midkine expression correlates with desmoid tumor recurrence: a potential biomarker and therapeutic target. The Journal of Pathology 2011; 225(4): 574-582.

Moore-Olufemi SD, Herzog C, Warneke C,Gershenwald JE, Mansfield P, Ross M, Prieto V, Lally, KP, Hayes-Jordan A. Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients. Annals of Surgery 2011; 253(6): 1211-1215.

Bedikian AY, Johnson MM, Warneke CL, Papadopoulos NE, Kim KB, Hwu WJ, McIntyre S, Rohlfs M, Homsi J, Hwu P. Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival? Melanoma Research 2011; 21(1): 84-90.

Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babier G, Kuerer HM, Hunt KK, Yang W, Sahin AA, Meric-Bernstam F. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Annals of Surgery 2011; 254(1): 119-124.

Chen JQ, Bao Yi, Litton J, Xiao L, Zhang HZ, Warneke CL, Wu Y, Shen X, Wu S, Katz RL, Sahin Am Bondy M, Murray JL, Radvanyi L. Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer. Hormones & Cancer 2011; 2(2): 132-143.

Ellerhorst JA, Greene VR, Ekmekcioglu S, Warneke CL, Johnson MM, Cooke CP, Wang LE, Prieto VG, Genshenwald JE, Wei Q, Grimm EA. Clinical correlates of NRAS and BRAF mutations in primary melanoma. Clinical Cancer Research 2011; 17(2): 229-235.

Chen JQ, Litton J, Xiao L, Zhang HZ, Warneke CL, Wu Y, Shen X, Wu S, Sahin A, Katz R, Bondy M, Hortobagyi G, Berinstein NL, Murray JL, Radvanyi L. Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer. Hormones & Cancer 2010; 1(1): 21-33.

Jonasch E, Corn P, Pagliaro LC, Warneke CL, Johnson MM, Tamboli P, Ng C, Aparicio A, Ashe RG, Wright JJ, Tannir NM. Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis. Cancer 2010; 116(1): 57-65.

Fearmonti RM, Gayed IW, Kim E, Bedrosian I, Hunt KK, Meric-Bernstam F, Feig B, Ghonimi E, Warneke C, Babiera GV. Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer. Annals of Surgical Oncology 2010; 17(1): 220-227.

Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. Journal of Bone and Mineral Research 2008; 23(6): 826-836.

Bedikian AY, Johnson MM, Warneke CL, McIntyre S, Papadopoulos N, Hwu WJ, Kim K, Hwu P. Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival. Journal of Immunotoxicology 2008; 5(2): 201-207.

Bedikian AY, Johnson MM, Warneke CL, Papadopoulos NE, Kim K, Hwu WJ, McIntyre S, Hwu P. Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma. Cancer Investigation 2008; 26(6): 624-633.

Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau SW, Bondy M, Mahabir S, Hortobagyi GN, Brewster AM. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. Journal of Clinical Oncology 2008; 1;26(25): 4072-4077.

Singh RS, Grayson W, Redston M, Diwan AH, Warneke CL, McKee PH, Lev D, Lyle S, Calonje E, Lazar AJ. Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. The American Journal of Surgical Pathology 2008; 32(6): 936-942.

Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D, Pollock RE, Lev D. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. American Journal of Pathology 2008; 173(5): 1518-1527.

Robson A, Lazar AJ, Ben Nagi J, Hanby A, Grayson W, Feinmesser M, Granter SR, Seed P, Warneke CL, McKee PH, Calonje E. Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases. The American Journal of Surgical Pathology 2008; 32(5): 682-690.

Lazar AJ, Das P, Tuvin D, Korchin B, Zhu Q, Jin Z, Warneke CL, Zhang PS, Hernandez V, Lopez-Terrada D, Pisters PW, Pollock RE, Lev D. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma. Clinical Cancer Research 2007; 15;13(24): 7314-7321.

Chakravarti N, Lotan R, Diwan AH, Warneke CL, Johnson MM, Prieto VG. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clinical Cancer Research 2007; 13(16): 4817-4824.

Gupta S, Jain A, Warneke CL, Gupta A, Shannon VR, Morice RC, Onn A, Jimenez CA, Bashoura L, Giralt SA, Dickey BF, Eapen GA. Outcome of alveolar hemorrhage in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation 2007; 40(1): 71-78.

Smith ML, Gremillion G, Slomka J, Warneke CL. Texas hospitals' experience with the Texas Advance Directives Act. Critical Care Medicine 2007; 35(5): 1271-1276.

Ghanem GA, Boktour M, Warneke C, Pham-Williams T, Kassis C, Bahna P, Aboufaycal H, Hachem R, Raad I. Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications. Medicine (Baltimore) 2007; 86(1): 54-60.

Sarkiss MG, Yusuf SW, Warneke CL, Lakkis NM, Hirch-Ginsburg CF, Champion JC, Swafford J, Shaw ADS, Lenihan DJ, Durand JB. Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer 2007; 109: 621-627.

Lu Z, Luo RZ, Peng H, Rosen DG, Atkinson EN, Warneke C, Huang M, Nishmoto A, Liu J, Liao WSL, Yu Y, Bast RC. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clinical Cancer Research 2006; 12: 2404-2413.

Goel V, Lazar AJF, Warneke CL, Redston MS, Haluska FG. Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma. Journal of Investigative Dermatology 2006; 126(1): 154-160.

Eder AM, Sui X, Rosen DG, Nolden LK, Cheng KW, Lahad JP, Kango-Singh M, Lu KH, Warneke CL, Atkinson EN, Bedrosian I, Keyomarsi K, Kuo WL, Gray JW, Yin JC, Liu J, Halder G, Mills GB. Atypical PKC{iota} contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer. Proceedings of the National Academy of Science of the United States of America 2005;102(35): 12519-12524.

Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA. Seeking help for erectile dysfunction after treatment for prostate cancer. Archives of Sexual Behavior 2004; 33(5): 443-454.

Wallace MJ, Madoff DC, Ahrar K, Warneke CL. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting. Cancer 2004; l101(2): 337-345.

Cohen L, Warneke C, Fouladi RT, Rodriguez MA, Chaoul-Reich A. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 2004; 100(10): 2253-2260.

Burton AW, Hassenbusch SJ, Warneke CL, Racz G, Stanton-Hicks M. Complex regional pain syndrome (CRPS): survey of current practices. Pain Practice 2004; 4(2): 74-83.

Jenkins R, Schover LR, Fouladi RT, Warneke C, Neese L, Klein EA, Zippe C, Kupelian P. Sexuality and health-related quality of life after prostate cancer in African-American and white men treated for localized disease. Journal of Sex & Marital Therapy 2004; 30(2): 79-93.

Basen-Engquist K, Shinn E, Warneke C, de Moor C, Le T, Richards-Kortum R, Follen M. Patient distress and satisfaction with optical spectroscopy in cervical dysplasia detection. American Journal of Obstetrics & Gynecology 2003; 189(4): 1136-1142.

Prokhorov AV, Warneke C, de Moor C, Emmons KM, Jones MM, Rosenblum C, Suchanek Hudmon K, Gritz ER. Self-reported health status, health vulnerability, and smoking behavior in community college students: implications for intervention. Nicotine & Tobacco Research 2003; 5(4): 545-552.

Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer 2002; 95(11): 2397-2407.

de Moor C, Sterner J, Hall M, Warneke CL, Gilani Z, Amato R, Cohen L. A pilot study of the effects of expressive writing on psychological and behavioral adjustment in patients enrolled in a phase II trial of vaccine therapy for metastatic renal cell carcinoma. Health Psychology 2002; 21(6): 615-619.

Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 2002; 95(8): 1773-1785.

Cullen KW, Ash DM, Warneke C, de Moor C. Intake of soft drinks, fruit-flavored beverages, and fruits and vegetables by children in grades 4 through 6. American Journal of Public Health 2002; 92(9): 1475-1478.

Warneke CL, Davis M, de Moor CA, Baranowski T. A 7-item versus 31-item food frequency questionnaire for measuring fruit, juice, and vegetable intake among a predominantly African-American population. Journal of the American Dietetic Association 2001; 101(7): 774-779.

Cullen KW, Baranowski T, Warneke CL, de Moor CA, Baranowski J, Nwachokor A, Hajek RA, Jones LA. “5 A Day” achievement badge for urban boy scouts: formative evaluation results. Journal of Cancer Education 1998; 13(3): 162-168.

Warneke CL, Cooper SC. Child and adolescent drownings in Harris County, Texas 1983 through 1990. American Journal of Public Health 1994; 84(4): 593-598.

Lockshin A, Giovanella BC, Mendoza JT, Warneke CL, Stehlin JS Jr. Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells. Cancer Treatment Reports 1985; 69(7-8): 845-850.


Updated March 7, 2013